These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3059929)

  • 21. A Dual Hit Model for Dopamine in Schizophrenia.
    Abi-Dargham A
    Biol Psychiatry; 2017 Jan; 81(1):2-4. PubMed ID: 27876155
    [No Abstract]   [Full Text] [Related]  

  • 22. Brain amines and peptides--their relevance to psychiatry.
    Smith GC; Copolov D
    Aust N Z J Psychiatry; 1979 Dec; 13(4):283-91. PubMed ID: 44187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of schizophrenic psychoses with gamma-type endorphins.
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Biol Psychiatry; 1982 Jan; 17(1):83-98. PubMed ID: 6174158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Schizophrenia and dopamine (author's transl)].
    Toru M
    Tanpakushitsu Kakusan Koso; 1978; 23(4):303-16. PubMed ID: 26107
    [No Abstract]   [Full Text] [Related]  

  • 25. [Schizophrenia as a dopamine excess syndrome].
    Toru M
    Nihon Rinsho; 1983 May; 41(5):1021-7. PubMed ID: 6138444
    [No Abstract]   [Full Text] [Related]  

  • 26. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of schizophrenic psychoses with gamma-type endorphins].
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Ned Tijdschr Geneeskd; 1981 Nov; 125(48):1963-9. PubMed ID: 6171738
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased dopamine-receptor sensitivity in schizophrenia.
    Owen F; Cross AJ; Crow TJ; Longden A; Poulter M; Riley GJ
    Lancet; 1978 Jul; 2(8083):223-6. PubMed ID: 79025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does dopamine have a role in schizophrenia?
    Carlsson A
    Biol Psychiatry; 1978 Feb; 13(1):3-21. PubMed ID: 341997
    [No Abstract]   [Full Text] [Related]  

  • 30. Neurotransmitters and CNS disease. Schizophrenia.
    Snyder SH
    Lancet; 1982 Oct; 2(8305):970-4. PubMed ID: 6127468
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biochemical studies of schizophrenia].
    Kakimoto Y
    Nihon Rinsho; 1976 Sep; 34(9):2706-11. PubMed ID: 1033308
    [No Abstract]   [Full Text] [Related]  

  • 32. Antipsychotic action of gamma-type endorphins: animal and human studies.
    van Ree JM; Verhoeven WM; Claas FH; de Wied D
    Prog Brain Res; 1986; 65():221-35. PubMed ID: 2431435
    [No Abstract]   [Full Text] [Related]  

  • 33. Behavioral effects of central catecholamines: concluding remarks.
    Vogt M
    J Psychiatr Res; 1974; 11():183-4. PubMed ID: 4461789
    [No Abstract]   [Full Text] [Related]  

  • 34. Integrating the neurobiology of schizophrenia. Preface.
    Abi-Dargham A; Guillin O
    Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neurochemistry and clinical psychiatry (author's transl)].
    Gross G
    Fortschr Neurol Psychiatr; 1981 Jan; 49(1):34-42. PubMed ID: 6971791
    [No Abstract]   [Full Text] [Related]  

  • 36. Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry.
    Bivehed E; Strömvall R; Bergquist J; Bakalkin G; Andersson M
    Peptides; 2017 Jan; 87():20-27. PubMed ID: 27840228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 38. Schizophrenia.
    Morrison PD; Murray RM
    Curr Biol; 2005 Dec; 15(24):R980-4. PubMed ID: 16360673
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation and characterization of in vitro central beta-endorphin metabolism in schizophrenia.
    Davis TP; Schoemaker H; Culling AJ; Yamamura HI
    Proc West Pharmacol Soc; 1983; 26():89-94. PubMed ID: 6310636
    [No Abstract]   [Full Text] [Related]  

  • 40. Involvement of neuropeptide systems in schizophrenia: human studies.
    Cáceda R; Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2007; 78():327-76. PubMed ID: 17349866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.